Insight Molecular Diagnostics Inc. - Common Stock (IMDX)

Historical Holders from Q2 2023 to Q3 2025

Type / Class
Equity / Common Stock
Symbol
IMDX on Nasdaq
Shares outstanding
17,417,453
Price per share
$3.32
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
16,282,884
Holdings value
$54,051,121
% of all portfolios
0%
Share change
+87,364
Value change
+$296,696
Average buys %
+0%
Average sells %
-0%
Number of holders
27
Price from insider filings
$6.01
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Insight Molecular Diagnostics Inc. - Common Stock (IMDX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BROADWOOD PARTNERS, L.P. 40% $32,137,773 11,560,350 NEAL C. BRADSHER 06 Feb 2025
AWM Investment Company, Inc. 10% +31% $7,942,652 +$4,311,113 2,857,069 +119% AWM Investment Company, Inc. 31 Mar 2025
As of 30 Sep 2025, Insight Molecular Diagnostics Inc. - Common Stock (IMDX) has 27 institutional shareholders filing 13F forms. They hold 16,282,884 shares of 17,417,453 outstanding shares (93%) .

Top 25 institutional shareholders own 93% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BROADWOOD CAPITAL INC 66% 11,410,100 0% 2.3% $37,881,532
AWM Investment Company, Inc. 16% 2,822,530 0% 0.88% $9,370,800
PURA VIDA INVESTMENTS, LLC 5.4% 947,134 0% 20% $3,144,485
VANGUARD GROUP INC 2.8% 486,738 +0.61% 0% $1,615,970
GEODE CAPITAL MANAGEMENT, LLC 1.1% 198,453 +26% 0% $658,937
BlackRock, Inc. 0.5% 87,951 +1.7% 0% $291,998
MILLENNIUM MANAGEMENT LLC 0.42% 73,291 +319% 0% $243,326
MORGAN STANLEY 0.36% 62,208 0% 0% $206,531
FNY Investment Advisers, LLC 0.3% 53,077 +115% 0.06% $176,000
STATE STREET CORP 0.24% 41,854 +114% 0% $138,955
NORTHERN TRUST CORP 0.19% 32,890 0% 0% $109,195
RENAISSANCE TECHNOLOGIES LLC 0.14% 23,600 -9.6% 0% $78,352
CITADEL ADVISORS LLC 0.07% 11,787 -62% 0% $39,133
OSAIC HOLDINGS, INC. 0.06% 11,216 +788% 0% $29,324
Private Advisor Group, LLC 0.06% 10,416 0% $34,581
EverSource Wealth Advisors, LLC 0.03% 5,000 0% 0% $16,600
UBS Group AG 0.02% 2,714 -82% 0% $9,011
Tower Research Capital LLC (TRC) 0% 624 -86% 0% $2,072
ORG Partners LLC 0% 450 -59% 0% $1,494
BANK OF AMERICA CORP /DE/ 0% 446 -22% 0% $1,481
SBI Securities Co., Ltd. 0% 185 0% 0% $614
JPMORGAN CHASE & CO 0% 154 0% 0% $511
BNP PARIBAS FINANCIAL MARKETS 0% 30 0% 0% $100
Piscataqua Savings Bank 0% 25 0% 0% $82
ALBION FINANCIAL GROUP /UT 0% 7 0% 0% $24

Institutional Holders of Insight Molecular Diagnostics Inc. - Common Stock (IMDX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 16,282,884 $54,051,121 +$296,696 $3.32 27
2025 Q2 15,248,594 $46,050,393 +$442,511 $3.02 29
2025 Q1 16,047,858 $49,105,818 +$23,516,170 $3.06 29
2024 Q4 8,368,457 $19,916,471 +$2,875,052 $2.38 24
2024 Q3 7,107,091 $20,255,014 +$3,161,740 $2.85 19
2024 Q2 5,990,280 $17,670,609 -$12,147 $2.95 21
2024 Q1 123,515 $362,459 -$1,174 $2.93 3
2023 Q4 3,624,342 $9,059,295 -$206,369 $2.50 24
2023 Q3 3,718,862 $11,617,455 +$11,613,890 $3.12 26
2023 Q2 15,000 $3,450 +$3,450 $0.2300 1